Status:
WITHDRAWN
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
Lead Sponsor:
University of Oklahoma
Conditions:
Endometrioma
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The aim of this study is to determine whether or not continuous combined oral contraceptive pills (COCP's) decrease the risk of recurrent endometrioma formation. The investigators' hypothesis is that ...
Detailed Description
We plan to identify patients planning to undergo conservative surgery for endometrioma at the University of Oklahoma private practice OB/GYN clinic and at the University of Oklahoma Resident Women's c...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of ovarian endometriotic cyst that has been surgically excited.
Exclusion
- Current desire to achieve pregnancy or other contraindication to combined oral contraceptive pills.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00999479
Start Date
October 1 2009
End Date
October 1 2011
Last Update
December 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104